• Home
  • Solutions
    • Cell sourcing
      • Cell therapy starting material
      • Immunogenetics & bioinformatics
      • Personalized cell therapy supply chain case management
    • Cell therapy supply chain
      • Collection network development
      • Cell delivery & logistics
      • Personalized cell therapy supply chain case management
      • MatchSource software
    • Clinical research support
      • Clinical trial design
      • Observational research
      • Biorepository & sample access
    • Collection network management
    • Quality & regulatory services
    • Quality System Audit Program
    • MatchSource software
    • Outcomes data reporting
  • About Us
    • History
    • Leadership
    • Upcoming Events
    • Careers
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Podcast
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us
  • Twitter
  • LinkedIn
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
Be The Match BioTherapies
MENUMENU
  • Solutions
        • Cell sourcing
          • Cell therapy starting material
          • Immunogenetics & bioinformatics
          • Personalized cell therapy supply chain case management
          • MatchSource software
        • Cell therapy supply chain
          • Collection network development
          • Cell delivery & logistics
          • Personalized cell therapy supply chain case management
        • Clinical research support
          • Clinical trial design
          • Observational research
          • Biorepository & sample access
        • Collection network management
        • Outcomes data reporting
        • Quality & regulatory services
        • Quality System Audit Program
  • About Us
    • History
    • Leadership
    • Our Partners
    • Upcoming Events
    • Careers
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Podcast
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us
Cell Lines

Cell Therapy Manufacturing and Gene Therapy Congress

Be The Match BioTherapies · Events · December 21, 2017

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

For the Be The Match BioTherapies team, the holiday season means conferences—and first up this December was the annual Cell Therapy Manufacturing & Gene Therapy Congress.

This year’s Congress, held at the beautiful RAI Convention Centre in Amsterdam, came on the heels of the first commercial approvals of genetically-modified cell therapies by the U.S. Food and Drug Administration (FDA). But, rather than celebrate CAR-T’s commercial splash, many of the attendees turned their attention to the practical challenges facing the industry in the months and years ahead.

The first panel session ‘The Realities of Manufacturing and Commercializing CAR-T cells and Gene Therapies,’ wasted no time highlighting the limitations of current manufacturing technology, and the need for innovation in the field if cell therapy is going to be successful on a commercial scale.

Of particular interest to many attendees was the issue of automation, and how companies are scaling up, and scaling out, their manufacturing units to reduce cost and meet the expected demand. Dolores Baksh discussed GE’s comprehensive manufacturing platform, which has expanded to include a multitude of automated systems from apheresis collection all the way through to the actual production of the CAR-T therapies. Nina Bauer from Lonza Biologics discussed their recent investment in Octane Biotech’s Cocoon cell production platform for personalized cell therapy.

Supply chain logistics also emerged as a hot topic.  As more cell and gene therapies enter the market, the supply chains are becoming more complex. Health care providers and industry stakeholders are turning to technology—such as MatchSource®, Be The Match BioTherapies’ supply-chain technology platform—to provide integrated solutions, address gaps in process and increase needle-to-needle efficiency for stakeholders at every level. During a presentation on the topic, Be The Match BioTherapies president, Amy Ronneberg, discussed the complexities of the cell therapy supply chain, and offered strategies for mitigating risk to successfully deliver cell therapies to patients in need.

The big takeaway from the conference? Cell and gene therapies have officially arrived, but their future success will require continued innovation, integration and coordination between suppliers and manufacturers.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
About the Author
Be The Match BioTherapies

Be The Match BioTherapies

Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development – from discovery through commercialization. Built on the foundation established over the last 30 years by the National Marrow Donor Program (NMDP)/Be The Match, we have unparalleled experience managing cellular therapies. Our cell therapy supply chain delivery for autologous or allogeneic therapies is enabled by high-touch, personalized case management and a technology platform, MatchSource®. Our experience in cell sourcing and collection allows us to provide cells consented for research, clinical or commercial use. Researchers have access to clinical trial services through our research program CIBMTR. And, we have the infrastructure in place to collect, store and analyze patient samples post-cell or gene therapy treatment at the time points required by regulatory authorities.

More Posts →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Close
Be The Match Biotherapies®
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
  • Contact

Copyright © 2019 Be The Match BioTherapies. All Rights Reserved.

  • bethematch.org →

    Information and support for patients, donors and supporters of our mission.

  • bethematchclinical.org →

    The latest transplant information for Clinicians, Network, Payers and Bioinformatics.

  • cibmtr.org →

    Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.